Panel hears primer on how health-care dollars flow and limits of state regulation

At a March meeting of the House Health Care Committee, an invited presenter gave an overview of how money moves through the health-care system and outlined the practical limits on what state regulators can change.

The presenter said the U.S. system differs from a classic market because of imperfect information, concentrated provider markets and widespread third‑party payers — entities that pay for care other than the patient — and urged the committee to focus on which regulatory levers actually affect different parts of the system.

The presenter opened with a widely used finding: a small fraction of patients account for the majority of spending. “Imagine Vermonters lined up from the least expensive to the most expensive. The most expensive 10% are somewhere between two‑thirds and three‑quarters of all health‑care spending,” the presenter said, describing examples such as very premature infants and complex cancer care.

Why it matters: that concentration means pooled payment systems are essential to finance catastrophic care, and it also limits what price‑ or transparency‑based reforms can achieve unless paired with quality measures.

The briefing described three broad payer types and how each constrains state action. Private insurers collect premiums; employers may be fully or partly self‑insured (the presenter said roughly 200,000 Vermonters work for self‑insured employers). Federal entitlement programs — Medicare for seniors and certain disabled people and Medicaid for low‑income families, children and some people with disabilities — set reimbursement rates rather than negotiating them. The presenter noted that Medicare and Medicaid “are an entitlement, which simply means if you meet the requirements you're in.”

State regulatory tools discussed included insurance premium regulation (limited to people with fully insured commercial coverage), hospital budgets and certificate‑of‑need review for major capital projects. The presenter said the Green Mountain Care Board can regulate hospital charges that affect commercial payers and that premium regulation covers a subset of Vermonters — the briefing cited an estimate of about 90,000 Vermonters affected by state premium regulation.

Panel members pressed on leverage and market power. One committee member noted Vermont’s small market and asked whether forcing hospitals to contract with commercial insurers would restore bargaining balance; the presenter said forcing participation would remove the negotiating leverage that exists when a party can “walk away,” and deferred to others on the legal implications. Sarah Teachout of Blue Cross Blue Shield of Vermont added a direct regulatory constraint for payers: “Insurers are required to have network adequacy, which means we have to have, in our network of providers for all of our members just to have good access to care,” which she said effectively requires contracting with most major providers in Vermont.

The presenter discussed alternative payment approaches, including capitation and global budgets. He described capitation as a fixed per‑patient payment meant to remove the fee‑for‑service incentive to increase volume, and said global budgets (a single fixed budget for a hospital) can be a powerful spending control but are difficult to implement in the U.S. because of multiple payers and cross‑border flows. The presenter described a Canadian hospital example and warned that applying a global budget in a U.S. state with crossing public and private payers is “not easy.”

The committee also discussed history and prospects for broader reform. The presenter reviewed historical drivers of the employer‑based system (Blue Cross/Blue Shield origins and World War II wage‑and‑benefits dynamics) and recent Vermont debates such as the Shao report and Act 40b. He said large changes often stumble on how taxes are presented and perceived: “People are convinced their employer gives them health insurance. They don't view it as they are foregoing income in order to get health insurance,” and that proposals to replace premiums with taxes often fail politically when presented as a new tax rather than a reallocation of existing spending.

Committee members asked about downstream effects on hospitals and access. The presenter gave Vermont spending figures cited during the briefing as approximate: "2020 about $6,400,000,000 spent for care of Vermonters," with roughly "$2,200,000,000 of that" for hospital care; the presenter also said another estimate placed total Vermont health spending at about $6,800,000,000 for the same year, and called attention to care flowing out of state (patients seeking specialty care elsewhere) as a limit on what Vermont’s regulators can control.

Panelists and the presenter agreed that nonmedical determinants of health — housing, nutrition, education, and targeted programs such as diabetes education — have produced measurable improvements and are often cost‑effective investments. The presenter also flagged contingency management (a form of motivational incentives to support substance‑use treatment) as an example where “we're paying people to be healthy” in limited, evidence‑based circumstances.

The session closed with lawmakers and the presenter noting that while many technical options exist (rate‑setting, budgets, certificate of need, alternative payment models), each faces political, market or legal constraints — for example, ERISA limits what states can require of self‑insured employers — and that any move toward system‑wide redesign needs both technical detail and public-facing explanations of who would pay and who would benefit.

The committee did not take formal action on any proposal during the hearing; the briefing was informational.